NASDAQ:UPC Universe Pharmaceuticals (UPC) Stock Price, News & Analysis $4.86 +0.11 (+2.32%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$4.58 -0.29 (-5.86%) As of 09/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsSEC Filings About Universe Pharmaceuticals Stock (NASDAQ:UPC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get UPC alerts:Sign Up Key Stats Today's Range$4.63▼$4.9050-Day Range$3.16▼$7.0952-Week Range$2.00▼$17.96Volume82,601 shsAverage Volume330,408 shsMarket Capitalization$24.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Universe Pharmaceuticals Inc. (NASDAQ: UPC) is a China-based pharmaceutical and healthcare products company. The company develops, manufactures and markets pharmaceutical products, health supplements and medical devices, with an emphasis on traditional Chinese medicine and other products used in everyday healthcare. Its product portfolio includes over-the-counter and prescription medicines designed to address a range of conditions, including respiratory, cardiovascular, digestive and dermatological ailments. Universe Pharmaceuticals also offers healthcare products and related medical devices through its distribution and sales channels. The company is headquartered in Xi’an, Shaanxi Province, China, and primarily serves the Chinese market. Universe Pharmaceuticals has operated in the pharmaceutical and healthcare sector since the late 1990s and has expanded its business through manufacturing, product development and commercial distribution activities.AI Generated. May Contain Errors. Read More Universe Pharmaceuticals Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks13th Percentile Overall ScoreUPC MarketRank™: Universe Pharmaceuticals scored higher than 13% of companies evaluated by MarketBeat, and ranked 844th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingUniverse Pharmaceuticals has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageUniverse Pharmaceuticals has only been the subject of 1 research reports in the past 90 days.Read more about Universe Pharmaceuticals' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioUniverse Pharmaceuticals has a P/B Ratio of 0.05. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.39% of the float of Universe Pharmaceuticals has been sold short.Short Interest Ratio / Days to CoverUniverse Pharmaceuticals has a short interest ratio ("days to cover") of 1.09, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Universe Pharmaceuticals has recently decreased by 15.90%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUniverse Pharmaceuticals does not currently pay a dividend.Dividend GrowthUniverse Pharmaceuticals does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 2 people have searched for UPC on MarketBeat in the last 30 days. This is a decrease of -78% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Universe Pharmaceuticals insiders have not sold or bought any company stock.Percentage Held by Insiders57.38% of the stock of Universe Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions0.18% of the stock of Universe Pharmaceuticals is held by institutions.Read more about Universe Pharmaceuticals' insider trading history. Receive UPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Universe Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. UPC Stock News HeadlinesUniverse Pharmaceuticals shares rise 22.6% premarket with no new catalyst identifiedSeptember 2, 2026 | msn.comUniverse Pharmaceuticals (UPC) stock soars over 38% after-hours: Here's what's going onSeptember 2, 2026 | msn.com$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its entire military budget. Central banks have bought over 1,000 tonnes of gold a year for three years running, trading paper for metal.September 20 at 1:00 AM | American Alternative (Ad)Universe Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:UPCJuly 18, 2026 | benzinga.comUniverse Pharmaceuticals INC - Ordinary Shares - Class AJuly 17, 2026 | money.usnews.comUniverse Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:UPC | BenzingaJune 29, 2026 | benzinga.com4 Sizzling Biotech and Healthcare Companies Reporting Strategic MilestonesJune 29, 2026 | markets.businessinsider.comUniverse Pharmaceuticals INC.: Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent PortfolioJune 27, 2026 | finanznachrichten.deSee More Headlines UPC Stock Analysis - Frequently Asked Questions How have UPC shares performed this year? Universe Pharmaceuticals' stock was trading at $3.81 at the start of the year. Since then, UPC shares have increased by 27.6% and is now trading at $4.86. How were Universe Pharmaceuticals' earnings last quarter? Universe Pharmaceuticals INC (NASDAQ:UPC) issued its quarterly earnings data on Wednesday, July, 29th. The company reported ($1.38) earnings per share for the quarter. The company had revenue of $4.52 million for the quarter. When did Universe Pharmaceuticals' stock split? Shares of Universe Pharmaceuticals reverse split on Wednesday, November 13th 2024.The 1-15 reverse split was announced on Wednesday, November 13th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Universe Pharmaceuticals IPO? Universe Pharmaceuticals (UPC) raised $30 million in an initial public offering (IPO) on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at $5.00-$7.00 per share. Univest Securities, LLC served as the underwriter for the IPO. How do I buy shares of Universe Pharmaceuticals? Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings7/29/2026Today9/20/2026Fiscal Year End9/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (3w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 3 weeks, UPC's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:UPC Previous SymbolNYSE:UPC CIK1809616 Webwww.universe-pharmacy.com Phone86-0796-8403309FaxN/AEmployees216Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.04 Current Ratio4.05 Quick Ratio3.90 Sales & Book Value Annual Sales$17.86 million Price / Sales1.37 Cash FlowN/A Price / Cash FlowN/A Book Value$99.64 per share Price / Book0.05Miscellaneous Outstanding Shares5,020,000Free Float2,141,000Market Cap$24.40 million OptionableN/A Beta1.58 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:UPC) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners“Elon’s nightmare” could fund your retirementMarc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredNVDA CEO says it’s a "once-in-a-generation opportunity"NVIDIA CEO Jensen Huang calls a little-known AI niche a once-in-a-generation opportunity, and it has nothing t...Monument Traders Alliance | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredIran War: Why Is Trump Protecting THEM?A powerful Middle Eastern government is reportedly seeking US intelligence, targeting help, and military prote...Banyan Hill Publishing | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
